Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 5. Inhibitory effect of S1P2 deficiency on level of pro-fibrotic protein in lung tissues. (A) Western blotting results of pro-fibrotic proteins (α-SMA), performed using protein isolated from lung tissues, on the 28th day after bleomycin treatment. (B) Protein levels were expressed as ratios with β-actin levels. The values shown are mean ± SE (n=6). Statistical significance: ***p<0.001 vs. PBS-treated S1P2 WT mice, #p<0.05 vs. PBS-treated S1P2 KO mice, and ††p<0.01 vs. bleomycin-treated S1P2 WT mice.
Biomol Ther 2019;27:318~326 https://doi.org/10.4062/biomolther.2018.131
© Biomolecules & Therapeutics